http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-717214-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7b7a22f6225654fae7d0795601ccb79
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088
filingDate 1952-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1954-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-717214-A
titleOfInvention Improvements relating to anaesthetics
abstract The invention comprises anaethestics of the formula <FORM:0717214/IV (b)/1> where R1 and R3 are alkyl or alkoxy groups, R2 is hydrogen or an alkyl or alkoxy group, R4 is a hydrocarbon chain of up to 6 carbon atoms, and R5 and R6 are hydrogen or alkyl groups which, with the nitrogen, may form a heterocyclic ring. They may be prepared by reacting an isocyanate of the formula <FORM:0717214/IV (b)/2> with an amino alcohol of the formula <FORM:0717214/IV (b)/3> with or without an inert solvent, e.g. benzene or toluene, first with cooling and then by boiling for one or two hours. The amino alcohol may be used in the form of its salt. In the examples: (1) 2,6-dimethyl-4-tert.-butyl carbanilic acid-b -piperidino-ethyl ester is prepared from 2,6-dimethyl-4-tert.-butyl phenyl isocyanate and b -piperidino-ethyl alcohol; (2) 2,6-dimethyl-4-n-butoxy carbanilic acid-g -diethylamino-propanol ester from 2,6 - dimethyl - 4 - n - butoxy phenyl isocyanate and 3-diethylaminopropanol-1; (3) 2,4,6-trimethyl-carbanilic acid-b -diethylamino ethyl ester hydrochloride is prepared from 2,4,6-trimethyl phenyl isocyanate and diethylaminoethyl alcohol. U.S.A. Specification 2,109,492 is referred to.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9531449-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3544579-A
priorityDate 1951-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID595239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154182407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416030422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432132417

Total number of triples: 30.